Vaccine for Modulating Between T1 and T2 Immune Responses
OwnerWladyslaw A. Budzynski, R. Rao Koganty +2inventors
InventorsWladyslaw A. Budzynski, R. Rao Koganty, Mark J. Krantz, B. Michael Longenecker
Life of this patent
Estimating the term…
Abstract
The present invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo.
Claims22
-81. (canceled)
A method for inducing a humoral immune response, comprising administering to an individual a formulation comprising:
- at least one liposome, which comprises a dilipopeptide, said dilipopeptide comprising at least eleven contiguous amino acids of either SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:4, and wherein two amino acids of said dilipopeptide are lipidated.
A liposomal composition comprising a dilipopeptide, said dilipopeptide comprising at least eleven contiguous amino acids of either SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:4, and wherein two amino acids of said dilipopeptide are lipidated.
Dependencies are inferred from the claim text.